French Real Estate Stock News

Pluxee N.V. recently announced that its Board of Directors is proposing a dividend distribution of €0.38 per ordinary share for fiscal 2025, reflecting a 9% year-on-year increase, pending approval at the upcoming annual General Meeting. This proposed dividend hike stands out as a tangible indicator of the company’s focus on rewarding shareholders and potentially highlights confidence in its underlying financial health. Given the company’s Board has signaled a heightened commitment to...

We.Connect SA's ( EPA:ALWEC ) robust recent earnings didn't do much to move the stock. We think this is due to...

Passive investing in an index fund is a good way to ensure your own returns roughly match the overall market. Active...

BNP Paribas (ENXTPA:BNP) reported earnings growth of 2.4% over the past year, falling short of its five-year average of 9.4% per year. Net profit margins slipped slightly to 23% from 23.6%, pointing to softer profitability. Looking ahead, earnings are forecast to grow at 7.9% per year, trailing the broader French market's 12.3% annual pace. However, revenue is expected to outpace the market at 7.2% per year. With shares trading at €66.94, well below both fair value estimates and analyst price...

Key Insights VusionGroup's significant retail investors ownership suggests that the key decisions are influenced by...

Bastide Le Confort Médical SA's ( EPA:BLC ) stock was strong despite it releasing a soft earnings report last week. We...

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Amongst other...

Key Insights Given the large stake in the stock by institutions, Valeo's stock price might be vulnerable to their...

Toosla Société Anonyme's ( EPA:ALTOO ) price-to-sales (or "P/S") ratio of 0.2x might make it look like a buy right now...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Key Insights ABIONYX Pharma's significant retail investors ownership suggests that the key decisions are influenced by...

When close to half the companies in France have price-to-earnings ratios (or "P/E's") above 17x, you may consider...

The MGI Digital Technology Société Anonyme ( EPA:ALMDG ) share price has fared very poorly over the last month, falling...

For many investors, the main point of stock picking is to generate higher returns than the overall market. But in any...

Mersen recently reported Q3 results that missed market expectations, citing ongoing weakness in its solar power segment and reducing its full-year organic sales growth, profit margin, and capital expenditure guidance due to a lack of recovery in this area. An important takeaway is that management expressed limited visibility on a turnaround in the solar segment, prompting analysts to anticipate downward revisions to consensus estimates for the company. We'll explore how weak activity and...

Mersen (ENXTPA:MRN) caught investor attention after its shares took a steep dive, following the release of Q3 results that fell short of expectations. This was driven largely by sluggish performance in its solar power segment. See our latest analysis for Mersen. After gaining impressive ground for much of 2024, Mersen's share price has now swung sharply as recent weak solar segment results rattled the market. The stock dropped 18.3% in a single day but still holds a 12.4% year-to-date price...

Vinci SA recently confirmed its 2025 earnings guidance following solid third-quarter results, reporting group revenue of €19.4 billion, up 4.7%, and continued growth in airport traffic and Energy Solutions segments. The company also highlighted that a one-off increase in France's corporate income tax for large companies is expected to reduce 2025 net income by an estimated €0.4 billion, underscoring its exposure to regulatory changes in its home market. We’ll assess how Vinci’s ability to...

Kering SA reported that its group revenue for the third quarter of 2025 was €3.42 billion, representing a 10% decline as reported and a 5% decline on a comparable basis, with performance at Gucci and across the portfolio showing sequential improvement over the previous quarter. In parallel, Kering agreed to sell its beauty division and certain fragrance licenses to L'Oréal for €4 billion in cash, aligning with a broader restructuring plan to refocus on fashion and reduce debt while entering...

Wendel (ENXTPA:MF) has seen a modest share price increase of 1.8% today and is up 4% over the past week. Investors might be reviewing the company’s recent performance and valuation as they consider next moves. See our latest analysis for Wendel. With today’s share price now at €82.0, Wendel’s recent gains have helped stem some of this year’s declines, though momentum has been uneven. The 1-year total shareholder return is still down 5.3%, but over three and five years, patient investors have...

Earlier this week, Compagnie Générale des Établissements Michelin Société en commandite par actions reported group sales of €19.28 billion for the nine months ended September 30, 2025, down from €20.17 billion a year earlier. This sales decrease, tied to market contractions and heightened competition in North America and Europe, prompted Michelin to revise its full-year guidance downward and lower profit forecasts. We'll assess how this sales decline and revised outlook impact Michelin's...

Thinking about what’s next for Amundi’s stock? You are not alone. Whether you have held on through the years or are weighing a new position, it is hard to ignore a company that has delivered nearly 71% growth over the past three years. Even if the pace has slowed, with a 3.0% rise so far this year and a modest 1.0% bump just this past week, there is a sense that something is stirring beneath the surface. Some of that recent uplift comes on the back of Amundi’s push into new markets and the...

Sanofi (ENXTPA:SAN) delivered net profit margins of 14%, up from 9.3% a year ago, and last year’s earnings grew 73.6% after five years of average annual declines of 14.5%. With earnings now forecast to climb 12.48% per year and profit and revenue expected to outpace the broader French market, these headline numbers make a strong case for a shift in investor sentiment. Improved profitability, a six-reward indicator profile, and a substantially lower Price-To-Earnings Ratio compared to peers...